Unlocking the Mystery of Prodromal MS With a Key Biomarker

The promise of serum neurofilament light chain to diagnose multiple sclerosis continues to evolve, with new evidence supporting a role in identifying presymptomatic disease.
Medscape Medical News

Source link

Related posts

Driving with dementia – new guidance for doctors


Does Intensive Blood Pressure Control Improve Cognition?


Why Awake DBS Is Still The Best Parkinson’s Disease Treatment


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy